These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7023898)

  • 1. Amikacin penetration into synovial fluid during treatment of septic arthritis.
    Honda DH; Adams HG; Barriere SL
    Drug Intell Clin Pharm; 1981 Apr; 15(4):284-6. PubMed ID: 7023898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
    Craven PC; Jorgensen JH; Kaspar RL; Drutz DJ
    Am J Med; 1977 Jun; 62(6):902-10. PubMed ID: 326046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amikacin treatment of Serratia septicemia in critically ill patients.
    Mosquera JM; de Villota ED; de la Serna JL; Diez-Balda V; Tomás MI; Galdos P; Rubio JJ
    Crit Care Med; 1981 Sep; 9(9):633-6. PubMed ID: 7023839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amikacin sulfate in mares: pharmacokinetics and body fluid and endometrial concentrations after repeated intramuscular administration.
    Brown MP; Embertson RM; Gronwall RR; Beal C; Mayhew IG; Curry SH
    Am J Vet Res; 1984 Aug; 45(8):1610-3. PubMed ID: 6476574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin-resistant Serratia marcescens endophthalmitis.
    Gammon JA; Schwab I; Joseph P
    Arch Ophthalmol; 1980 Jul; 98(7):1221-3. PubMed ID: 6994702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration.
    Orsini JA; Soma LR; Rourke JE; Park M
    J Vet Pharmacol Ther; 1985 Jun; 8(2):194-201. PubMed ID: 4020950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serratia arthritis in heroin users.
    Ross GN; Baraff LJ; Quismorio FP
    J Bone Joint Surg Am; 1975 Dec; 57(8):1158-60. PubMed ID: 1104628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    Maslow MJ; Simberkoff MS; Rahal JJ
    J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
    Wirt TC; McGee ZA; Oldfield EH; Meacham WF
    J Neurosurg; 1979 Jan; 50(1):95-9. PubMed ID: 363982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli infections in knee joints. The pharmacological and antibacterial effects of intramuscular antibiotics.
    Schurman DJ; Kajiyama G; Nagel DA
    J Bone Joint Surg Am; 1980; 62(4):620-7. PubMed ID: 6991503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, epidemiologic and microbiologic features of a persistent outbreak of amikacin-resistant Serratia marcescens.
    Arroyo JC; Milligan WL; Postic B; Northey J; Parker E; Bryan CS
    Infect Control; 1981; 2(5):367-72. PubMed ID: 7028654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment of Serratia arthritis with trimethoprim-sulfamethoxazole.
    Nair SR; Karthikeyan GS; Cherubin CE; Wallace SL
    Johns Hopkins Med J; 1978 Oct; 143(4):126-8. PubMed ID: 359887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serratia marcescens - caused arthritis with negative and positive birefrengent crystals.
    Mayer JW; DeHoratius RJ; Messner RP
    Arch Intern Med; 1976 Nov; 136(11):1323-5. PubMed ID: 791169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery.
    Cook LN; Davis RS; Stover BH
    Pediatrics; 1980 Feb; 65(2):264-8. PubMed ID: 6986597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serratia arthritis. Report of seven cases.
    Donovan TL; Chapman MW; Harrington KD; Nagel DA
    J Bone Joint Surg Am; 1976 Oct; 58(7):1009-11. PubMed ID: 789379
    [No Abstract]   [Full Text] [Related]  

  • 18. The penetration of metronidazole into synovial fluid.
    Sattar MA; Sankey MG; Cawley MI; Kaye CM; Holt JE
    Postgrad Med J; 1982 Jan; 58(675):20-4. PubMed ID: 7088754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of repeated intra-articular administration of amikacin on serum amyloid A, total protein and nucleated cell count in synovial fluid from healthy horses.
    Sanchez Teran AF; Rubio-Martinez LM; Villarino NF; Sanz MG
    Equine Vet J Suppl; 2012 Dec; (43):12-6. PubMed ID: 23447871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hip Synovial Fluid Cell Counts in Children From a Lyme Disease Endemic Area.
    Dart AH; Michelson KA; Aronson PL; Garro AC; Lee TJ; Glerum KM; Nigrovic PA; Kocher MS; Bachur RG; Nigrovic LE
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29669751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.